Recent Posts by Feyi Olopade Ayodele:
by Feyi Olopade Ayodele, on Jan 4, 2021 11:26:48 AM
In November, I attended the President’s Cancer Panel titled Improving Resilience and Equity in Cancer Screening: Lessons from COVID-19 and Beyond. This discussion series focused on screening across four cancer …
Read Storyby Feyi Olopade Ayodele, on Mar 25, 2020 2:10:01 PM
We've been amazed to see teams across the country pulling together to take their cancer genetics programs virtual during these challenging times. To show our support, we commit to: Share …
Read Storyby Feyi Olopade Ayodele, on Jan 31, 2020 12:34:44 PM
We speak with clients all of the time who are facing challenges justifying the investment in personnel and software support required to start, run, or grow their cancer genetic counseling …
Read Storyby Feyi Olopade Ayodele, on Dec 31, 2019 1:27:41 PM
Dear All, What a year it has been for CancerIQ! We are on a mission to predict, pre-empt, and prevent cancer - and in 2019 - we made significant strides …
Read Storyby Feyi Olopade Ayodele, on Dec 23, 2019 10:18:12 AM
With genetics becoming mainstream today, primary care has an opportunity to expand genetic counseling and testing to patients. Primary care providers play an important role in healthcare delivery. Often, until …
Read Storyby Feyi Olopade Ayodele, on Nov 8, 2019 1:35:31 PM
For years, the Marin General Hospital Breast Health Center had a successful high-risk breast cancer program, but decided to elevate their program by incorporating risk assessment software. By implementing a …
Read Storyby Feyi Olopade Ayodele, on Oct 9, 2019 12:06:22 PM
Mathew Knowles - Beyonce Knowles' father - revealed on Good Morning America that he is battling breast cancer, which was caused by a pathogenic BRCA2 mutation. The news coincided with …
Read Storyby Feyi Olopade Ayodele, on Aug 15, 2019 2:01:55 PM
There are over 157 million women in the United States. About 12 percent of those women will develop invasive breast cancer, according to the nonprofit group BreastCancer.org. That's over 18 …
Read Storyby Feyi Olopade Ayodele, on Jul 8, 2019 4:13:07 PM
Hereditary cancer risk assessment programs present an enormous value proposition for health systems. In the short-term, it can drive additional revenue through increased surveillance and preventative services. Over the long …
Read Storyby Feyi Olopade Ayodele, on Feb 26, 2019 3:12:35 PM
National Comprehensive Cancer Network (NCCN) guidelines for genetic testing should be updated, suggests a 2018 study published in the Journal of Oncology. The study looked at 959 breast cancer patients, and …
Read StoryAt CancerIQ, we're dedicated to making it easier for providers to offer cancer risk assessment to every patient that walks through the door. This starts with practical implementation methods and tools (like CancerIQ)! On our blog, we'll offer best practices and advice on how to streamline your cancer risk assessment program.
515 N. State, Suite 1025
Chicago, IL 60654
Call us: 312-761-3360
info@cancer-iq.com